BeyondSpring Inc. (BYSI) vs Seres Therapeutics, Inc. (MCRB)
A side-by-side comparison of BeyondSpring Inc. and Seres Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BYSI
BeyondSpring Inc.
$0.74HealthcareDelayed quote: Oct 6, 2026, 12:08 PM EDT
MCRB
Seres Therapeutics, Inc.
$2.85HealthcareDelayed quote: Oct 6, 2026, 12:04 PM EDT
Total return — BYSI vs MCRB
growth of $100 · dividends reinvested · last 10yBYSI -95.3% (-26.4%/yr)MCRB -98.5% (-34.1%/yr)BYSI compounded faster over this window
BYSI MCRB
BYSI vs MCRB: by the numbers
- •BYSI is the larger company ($30M vs $28M market cap).
- •Both run net losses; BYSI's is the smaller (0.00% vs -1192.94% net margin).
Metrics side by side
Valuation
| Metric | BYSI | MCRB |
|---|---|---|
| P/S ratio | N/A | 14.66 |
| P/B ratio | N/A | 0.80 |
Profitability
| Metric | BYSI | MCRB |
|---|---|---|
| Gross margin | 0.00% | -423.83% |
| Operating margin | 0.00% | -11910.14% |
| Net margin | 0.00% | -1192.94% |
| ROE | N/A | -65.05% |
| ROIC | N/A | -103.04% |
Growth (annualized)
| Metric | BYSI | MCRB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -42.51% |
| Total return CAGR (5Y) | -44.30% | -53.37% |
Frequently asked
- How have BYSI and MCRB total returns compared?
- Over the past 5 years, BYSI delivered -44.30% and MCRB delivered -53.37% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.